| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4825050 | Functional | Antileishmanial activity against promastigote form of Leishmania infantum assessed as inhibition of parasite growth | Leishmania infantum | 10 | ALA4823298 | organism-based format | Scientific Literature | |
| 2. | ALA4825051 | Functional | Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as reduction in parasite growth | Leishmania infantum | 3 | ALA4823298 | organism-based format | Scientific Literature | |
| 3. | ALA4825052 | ADME | Cytotoxicity against PBMC (unknown origin) | Not specified | 3 | ALA4823298 | tissue-based format | Scientific Literature | |
| 4. | ALA4825053 | Functional | Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as reduction in parasite growth at 6.25 to 12.5 ug/ml | Leishmania infantum | 2 | ALA4823298 | organism-based format | Scientific Literature | |
| 5. | ALA4825054 | Toxicity | Selectivity index, ratio of CC50 for PBMC (unknown origin) to EC50 for anti-leishmanial activity against axenic amastigote stage of Leishmania infantum | 3 | ALA4823298 | assay format | Scientific Literature | ||
| 6. | ALA4825055 | ADME | Cytotoxicity against human erythrocytes | Homo sapiens | 10 | ALA4823298 | cell-based format | Scientific Literature | |
| 7. | ALA4825056 | Functional | Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as reduction in parasite growth at 0.7812 ug/ml | Leishmania infantum | 2 | ALA4823298 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!